{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "breast and ovary cancer syndrome",
      "multiple primary malignant neoplasias",
      "targeted genomic sequencing"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "37047678",
  "DateCompleted": {
    "Year": "2023",
    "Month": "04",
    "Day": "14"
  },
  "DateRevised": {
    "Year": "2023",
    "Month": "04",
    "Day": "15"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2023",
        "Month": "04",
        "Day": "04"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "6705",
      "10.3390/ijms24076705"
    ],
    "Journal": {
      "ISSN": "1422-0067",
      "JournalIssue": {
        "Volume": "24",
        "Issue": "7",
        "PubDate": {
          "Year": "2023",
          "Month": "Apr",
          "Day": "04"
        }
      },
      "Title": "International journal of molecular sciences",
      "ISOAbbreviation": "Int J Mol Sci"
    },
    "ArticleTitle": "Genetic Analysis of Multiple Primary Malignant Tumors in Women with Breast and Ovarian Cancer.",
    "Abstract": {
      "AbstractText": [
        "Familial cancer syndromes, which are commonly caused by germline mutations in oncogenes and tumor suppressor genes, are generally considered to be the cause of primary multiple malignant neoplasias (PMMNs). Using targeted genomic sequencing, we screened for eight germline mutations: <i>BRCA1</i> 185delAG, <i>BRCA1</i> T300G, <i>BRCA1</i> 2080delA, <i>BRCA1</i> 4153delA, <i>BRCA1</i> 5382insC, <i>BRCA2</i> 6174delT, <i>CHEK2</i> 1100delC, and <i>BLM</i> C1642T, which provoke the majority of cases of hereditary breast and ovary cancer syndrome (HBOC), in genomic (blood) DNA from 60 women with PMMNs, including breast (BC) and/or ovarian cancer(s) (OC). Pathogenic allelic forms were discovered in nine samples: in seven instances, it was <i>BRCA1</i> 5382insC, and in the following two, <i>BRCA1</i> 4153delA and <i>BRCA1</i> T300G. The age of onset in these patients (46.8 years) was younger than in the general Russian population (61.0) for BC but was not for OC: 58.3 and 59.4, correspondingly. There were invasive breast carcinomas of no special type and invasive serous ovarian carcinomas in all cases. Two or more tumors of HBOC-spectrum were only in five out of nine families of mutation carriers. Nevertheless, every mutation carrier has relatives who have developed malignant tumors."
      ]
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Federal Research Center of Fundamental and Translational Medicine, Novosibirsk 630117, Russia."
          },
          {
            "Identifier": [],
            "Affiliation": "V. Zelman Institute for the Medicine and Psychology, Novosibirsk State University, Novosibirsk 630090, Russia."
          },
          {
            "Identifier": [],
            "Affiliation": "E. Meshalkin National Medical Research Center of Ministry of Health of Russian Federation, Novosibirsk 630055, Russia."
          }
        ],
        "LastName": "Savkova",
        "ForeName": "Alina",
        "Initials": "A"
      },
      {
        "Identifier": [
          "0000-0002-7693-3777"
        ],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Federal Research Center of Fundamental and Translational Medicine, Novosibirsk 630117, Russia."
          },
          {
            "Identifier": [],
            "Affiliation": "V. Zelman Institute for the Medicine and Psychology, Novosibirsk State University, Novosibirsk 630090, Russia."
          }
        ],
        "LastName": "Gulyaeva",
        "ForeName": "Lyudmila",
        "Initials": "L"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Federal Research Center of Fundamental and Translational Medicine, Novosibirsk 630117, Russia."
          },
          {
            "Identifier": [],
            "Affiliation": "Novosibirsk Region Clinical Oncology Center, Novosibirsk 630108, Russia."
          }
        ],
        "LastName": "Gerasimov",
        "ForeName": "Aleksey",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "V. Zelman Institute for the Medicine and Psychology, Novosibirsk State University, Novosibirsk 630090, Russia."
          },
          {
            "Identifier": [],
            "Affiliation": "E. Meshalkin National Medical Research Center of Ministry of Health of Russian Federation, Novosibirsk 630055, Russia."
          }
        ],
        "LastName": "Krasil'nikov",
        "ForeName": "Sergey",
        "Initials": "S"
      }
    ],
    "GrantList": [
      {
        "GrantID": "1",
        "Acronym": "CX",
        "Agency": "CSRD VA",
        "Country": "United States"
      }
    ],
    "PublicationTypeList": [
      "Journal Article"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Switzerland",
    "MedlineTA": "Int J Mol Sci",
    "NlmUniqueID": "101092791",
    "ISSNLinking": "1422-0067"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "BRCA2 Protein"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Female"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Middle Aged"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Germ-Line Mutation"
    },
    {
      "QualifierName": [
        "genetics",
        "pathology"
      ],
      "DescriptorName": "Ovarian Neoplasms"
    },
    {
      "QualifierName": [
        "pathology"
      ],
      "DescriptorName": "Breast Neoplasms"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Alleles"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "Neoplasms, Multiple Primary"
    },
    {
      "QualifierName": [
        "genetics"
      ],
      "DescriptorName": "BRCA2 Protein"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Mutation"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Genetic Predisposition to Disease"
    }
  ],
  "CoiStatement": "The authors declare no conflict of interest."
}